Log In
person
Alteogen Inc
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2020
| Reporting Segmentarrow_drop_up | Product Line | Amount (KRW) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (KRW) | Percentage |
| Goods |
Biosimilars; sold through distributor
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
1.56B | 5.35% |
| Merchandise |
Generic Pharmaceuticals
These companies manufacture generic drugs.
|
14.34B | 49.07% |
| Research Service |
Contract Research for Drug Manufacturers
These companies do contract services for biotech and pharmaceutical companies.
|
13.32B | 45.58% |
| keyboard_arrow_down |
Goods
Biosimilars; sold through distributor
|
1.56B | 5.35% |
| keyboard_arrow_right |
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
||
| keyboard_arrow_down |
Merchandise
Generic Pharmaceuticals
|
14.34B | 49.07% |
| keyboard_arrow_right |
These companies manufacture generic drugs.
|
||
| keyboard_arrow_down |
Research Service
Contract Research for Drug Manufacturers
|
13.32B | 45.58% |
| keyboard_arrow_right |
These companies do contract services for biotech and pharmaceutical companies.
|
||